Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study

NCT07499440 is registered in ClinicalTrials.gov with HB BioTech, LLC as lead sponsor.

NCT NCT07499440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07499440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
HB BioTech, LLC
Phase
Phase 2
Overall status
Recruiting
Start date
June 3, 2026
Completion date
October 31, 2027
Enrollment
200 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

mental illness, ptsd